AIM ImmunoTech Inc. (AIM) Financial Statements (2024 and earlier)

Company Profile

Business Address 2117 SW HIGHWAY 484
OCALA, FL 32801
State of Incorp. FL
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments34,19048,26838,5011,4702992,107
Cash and cash equivalents27,05332,09338,5011,4702991,412
Short-term investments7,13716,175   695
Receivables1,6761,6411,1248201,09424
Asset, held-for-sale, not part of disposal group      764
Other undisclosed current assets4553046858,1562,406610
Total current assets:36,32150,21340,31010,4463,7993,505
Noncurrent Assets
Operating lease, right-of-use asset829149179152
Property, plant and equipment1954,0476,4737,1167,7828,586
Intangible assets, net (including goodwill)1,9411,9741,4981,151912858
Intangible assets, net (excluding goodwill)1,9411,9741,4981,151912858
Other noncurrent assets1,2021,3167481,3541,3521,258
Other undisclosed noncurrent assets   15,376   
Total noncurrent assets:4,1677,48624,2749,77310,04610,702
TOTAL ASSETS:40,48857,69964,58420,21913,84514,207
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,1836368258751,6852,707
Accounts payable377198383472680741
Accrued liabilities8064384424031,0051,966
Debt   230252  
Other undisclosed current liabilities1783747 3,607 
Total current liabilities:1,3616731,1021,1275,2922,707
Noncurrent Liabilities
Long-term debt and lease obligation  1122,0082,2182,3181,835
Long-term debt, excluding current maturities   1,8762,1042,3181,835
Liabilities, other than long-term debt659     
Operating lease, liability659112132114
Total noncurrent liabilities:6592242,1402,2182,3181,835
Total liabilities:2,0208973,2423,3457,6104,542
Equity
Equity, attributable to parent, including:38,46856,87961,29412,9075,1748,703
Preferred stock 696715732   
Common stock484842104933
Additional paid in capital418,270417,217402,541340,228323,701317,419
Accumulated other comprehensive income (loss)   (47) (3)11
Accumulated deficit(380,546)(361,101)(341,974)(328,109)(318,573)(308,760)
Other undisclosed equity, attributable to parent   778  
Total equity:38,46856,87961,29412,9075,1748,703
Other undisclosed liabilities and equity  (77)483,9671,061962
TOTAL LIABILITIES AND EQUITY:40,48857,69964,58420,21913,84514,207

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues141135163140367437
Revenue, net437
Loss on disposition of assets for financial service operations(751)    
Cost of revenue (950)(941)(2,023)(1,517)(1,183)
Cost of goods and services sold (850)(806)(893)(884)(1,183)
Gross profit:141(815)(778)(1,883)(1,150)(746)
Operating expenses(20,064)(18,023)(14,374)(10,560)(10,346)(10,670)
Operating loss:(19,923)(18,838)(15,152)(12,443)(11,496)(11,416)
Nonoperating income (expense)(1,050)(201)    
Investment income, nonoperating(1,679)(201)    
Other nonoperating income629     
Interest and debt expense  (2,768)(530)(427)(502)(139)
Loss from continuing operations:(20,973)(21,807)(15,682)(12,870)(11,998)(11,555)
Loss before gain (loss) on sale of properties:(21,807)(15,682)(12,870)(11,998)(11,555)
Net loss:(20,973)(21,807)(15,682)(12,870)(11,998)(11,555)
Other undisclosed net income attributable to parent1,5282,6801,2823,3372,1853,296
Net loss available to common stockholders, diluted:(19,445)(19,127)(14,400)(9,533)(9,813)(8,259)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(20,973)(21,807)(15,682)(12,870)(11,998)(11,555)
Comprehensive loss:(20,973)(21,807)(15,682)(12,870)(11,998)(11,555)
Other undisclosed comprehensive income, net of tax, attributable to parent1,5282,7271,2353,3372,1713,312
Comprehensive loss, net of tax, attributable to parent:(19,445)(19,080)(14,447)(9,533)(9,827)(8,243)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: